Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more
Wellbiotec Co. Ltd. (010600) - Total Assets
Latest total assets as of December 2024: ₩31.95 Billion KRW
Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) holds total assets worth ₩31.95 Billion KRW as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wellbiotec Co. Ltd. - Total Assets Trend (2002–2024)
This chart illustrates how Wellbiotec Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Wellbiotec Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Wellbiotec Co. Ltd.'s total assets of ₩31.95 Billion consist of 75.0% current assets and 25.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 22.9% |
| Accounts Receivable | ₩9.76 Billion | 30.6% |
| Inventory | ₩0.00 | 0.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩224.53 Million | 0.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Wellbiotec Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wellbiotec Co. Ltd.'s current assets represent 75.0% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 22.9% of total assets in 2024, up from 1.6% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 30.6% of total assets.
Wellbiotec Co. Ltd. Competitors by Total Assets
Key competitors of Wellbiotec Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Textile Holdings Co Ltd
SHE:000045
|
China | CN¥5.28 Billion |
|
Kyungbangco.Ltd
KO:000050
|
Korea | ₩1.23 Trillion |
|
Shijiazhuang Changshan Textile Co Ltd
SHE:000158
|
China | CN¥17.37 Billion |
|
Jilin Chemical Fibre Co Ltd
SHE:000420
|
China | CN¥13.70 Billion |
|
Lu Thai Textile Co Ltd
SHE:000726
|
China | CN¥14.17 Billion |
|
Anhui Huamao Textile Co Ltd
SHE:000850
|
China | CN¥7.35 Billion |
|
Xinxiang Chemical Fiber Co Ltd
SHE:000949
|
China | CN¥13.36 Billion |
|
Chonbang
KO:000950
|
Korea | ₩236.79 Billion |
Wellbiotec Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Wellbiotec Co. Ltd. generates 2.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Wellbiotec Co. Ltd. is currently not profitable relative to its asset base.
Wellbiotec Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.23 | 1.88 | 1.59 |
| Quick Ratio | 2.23 | 1.80 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩13.24 Billion | ₩ 18.18 Billion | ₩ 22.85 Billion |
Wellbiotec Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Wellbiotec Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.30 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -47.0% |
| Total Assets | ₩31.95 Billion |
| Market Capitalization | $30.03 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wellbiotec Co. Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Wellbiotec Co. Ltd.'s assets decreased by 47.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Wellbiotec Co. Ltd. (2002–2024)
The table below shows the annual total assets of Wellbiotec Co. Ltd. from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩31.95 Billion | -46.97% |
| 2023-12-31 | ₩60.24 Billion | +0.05% |
| 2022-12-31 | ₩60.21 Billion | -56.00% |
| 2021-12-31 | ₩136.83 Billion | +92.93% |
| 2020-12-31 | ₩70.92 Billion | -40.81% |
| 2019-12-31 | ₩119.82 Billion | +7.80% |
| 2018-12-31 | ₩111.16 Billion | +27.76% |
| 2017-12-31 | ₩87.01 Billion | +45.34% |
| 2016-12-31 | ₩59.86 Billion | +1.31% |
| 2015-12-31 | ₩59.09 Billion | -3.53% |
| 2014-12-31 | ₩61.25 Billion | +0.04% |
| 2013-12-31 | ₩61.23 Billion | -0.95% |
| 2012-12-31 | ₩61.81 Billion | -13.13% |
| 2011-12-31 | ₩71.15 Billion | +18.13% |
| 2010-12-31 | ₩60.24 Billion | -0.13% |
| 2009-12-31 | ₩60.32 Billion | -39.57% |
| 2008-12-31 | ₩99.81 Billion | -5.48% |
| 2007-12-31 | ₩105.59 Billion | -27.62% |
| 2006-12-31 | ₩145.88 Billion | -3.49% |
| 2005-12-31 | ₩151.15 Billion | +17.02% |
| 2004-12-31 | ₩129.16 Billion | +6.93% |
| 2003-12-31 | ₩120.79 Billion | +20.94% |
| 2002-12-31 | ₩99.88 Billion | -- |